Page last updated: 2024-10-22

amitriptyline and Agranulocytosis

amitriptyline has been researched along with Agranulocytosis in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azadeh, N1
Kelemen, K1
Fonseca, R1
Litvak, R1
Kaelbling, R1

Other Studies

2 other studies available for amitriptyline and Agranulocytosis

ArticleYear
Amitriptyline-induced agranulocytosis with bone marrow confirmation.
    Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:5

    Topics: Agranulocytosis; Amitriptyline; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocol

2014
Agranulocytosis, leukopenia, and psychotropic drugs.
    Archives of general psychiatry, 1971, Volume: 24, Issue:3

    Topics: Adult; Agranulocytosis; Amitriptyline; Chlordiazepoxide; Chlorpromazine; Diazepam; Humans

1971